Modern approaches to understanding stress and disease susceptibility: A review with special emphasis on respiratory disease

International Journal of General Medicine

Volumn 2, Issue , 2009, Pages 19-32

  Aich, Palok ^a   Potter, Andrew A ^a   Griebel, Philip J ^a  

^a UNIVERSITY OF SASKATCHEWAN   (Canada)

Author keywords

Biomarker discovery; Disease; Omics; Respiratory disease; Stress; Systems biology

Indexed keywords

CHEMOKINE; CYTOKINE; HORMONE;

BIOINFORMATICS; DISEASE PREDISPOSITION; FOOD QUALITY; GENOMICS; HUMAN; MENTAL STRESS; METABOLOMICS; NONHUMAN; PROTEOMICS; RESPIRATORY TRACT DISEASE; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 73149090651     PISSN: None     EISSN: 11787074     Source Type: Journal    
DOI: 10.2147/ijgm.s4843     Document Type: Review

References (98)

1. Chrousos GP, Loriaux DL, Gold PW. The concept of stress and its historical development. Adv Exper Med Biol. 1988;245:3.
2. Griffin JFT. Stress and immunity: A unifying concept. Veterinary Immunology and Immunopathology. 1989;20(3):263-312.
3. Fraser SB, Richie JSD, Fraser AF. The term 'stress' in the veterinary context. Br Vet J. 1975;131:653-662.
4. Schwab CL, Fan R, Zheng Q, Myers LP, Hebert P, Pruett SB. Modeling and predicting stress-induced immunosuppression in mice using blood parameters. Toxicol Sci. 2005;83(1):101-113.
5. Buckley TM, Schatzberg AF. On the interactions of the hypothalamicpituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab. 2005;90(5):3106-3114.
6. Marsland AL, Bachen EA, Cohen S, Rabin B, Manuck SB. Stress, immune reactivity and susceptibility to infectious disease. Physiol Behav. 2002;77(4-5):711-716.
7. Yang EV, Glaser R. Stress-induced immunomodulation and the implications for health. Int Immunopharmacol. 2002;2(2-3):315-324.
8. Matarazzo JD, Weiss SM, Herd JA, Miller NE, Weiss SM. Behavioral health: A handbook for health enhancement and disease prevention. New York: Wiley; 1984.
9. Jemmott JB, 3rd, Locke SE. Psychosocial factors, immunologic mediation, and human susceptibility to infectious diseases: how much do we know? Psychol Bull. 1984;95(1):78-108.
10. Krantz DS, Grunberg NE, Baum A. Health psychology. Annu Rev Psychol. 1985;36:349-383.
11. Cohen S, Line S, Manuck SB, Rabin BS, Heise ER, Kaplan JR. Chronic social stress, social status, and susceptibility to upper respiratory infections in nonhuman primates. Psychosom Med. 1997;59(3):213-221.
12. Simonsen L, Fukuda K, Schonberger LB, Cox NJ. The impact of infl uenza epidemics on hospitalizations. J Infect Dis. 2000;181(3): 831-837.
13. Cohen S, Doyle WJ, Skoner DP. Psychological stress, cytokine production, and severity of upper respiratory illness. Psychosom Med. 1999;61(2):175-180.
14. Clover RD, Abell T, Becker LA, Crawford S, Ramsey CN, Jr. Family functioning and stress as predictors of infl uenza B infection. J Fam Pract. 1989;28(5):535-539.
15. Hermann G, Tovar CA, Beck FM, Allen C, Sheridan JF. Restraint stress differentially affects the pathogenesis of an experimental infl uenza viral infection in three inbred strains of mice. J Neuroimmunol. 1993;47(1):83-94.
16. Sheridan JF, Feng NG, Bonneau RH, Allen CM, Huneycutt BS, Glaser R. Restraint stress differentially affects anti-viral cellular and humoral immune responses in mice. J Neuroimmunol. 1991;31(3):245-255.
17. Deshpande SA, Northern V. The clinical and health economic burden of respiratory syncytial virus disease among children under 2 years of age in a defi ned geographical area. Arch Dis Child. 2003;88(12): 1065-1069.
18. Ganguin HG. [Respiratory tract diseases, their health-political importance and trends]. Z Gesamte Inn Med. 1979;34(4):18-20.
19. Kiecolt-Glaser JK, Glaser R. Psychosocial factors, stress, disease, and immunity. San Diego, CA: Academic Press; 1991. p. 849-867.
20. Graham NM, Douglas RM, Ryan P. Stress and acute respiratory infection. Am J Epidemiol. 1986;124(3):389.
21. Cohen S, Tyrrell DA, Smith AP. Psychological stress and susceptibility to the common cold. N Engl J Med. 1991;325(9):606-612.
22. Cohen S. Psychological stress and susceptibility to upper respiratory infections. Am J Respir Crit Care Med. 1995;152(4 Pt 2):S53-S58.
23. Turner-Cobb JM, Steptoe A. Psychosocial stress and susceptibility to upper respiratory tract illness in an adult population sample. Psychosom Med. 1996;58:404-412.
24. Cohen S, Williamson GM. Stress and infectious disease in humans. Psychol Bull. 1991;109(1):5-24.
25. Broadbent DE, Broadbent MHP, Phillpotts RJ, Wallace J. Some further studies on the prediction of experimental colds in volunteers by psychological factors. J Psychosom Res. 1984;28(6):511-523.
26. Beasley R, Coleman ED, Hermon Y, Holst PE, O'Donnell TV, Tobias M. Viral respiratory tract infection and exacerbations of asthma in adult patients. Thorax. 1988;43(9):679-683.
27. Hudgel DW, Langston L Jr, Selner JC, McIntosh K. Viral and bacterial infections in adults with chronic asthma. Am Rev Respir Dis. 1979;120(2):393-397.
28. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. BMJ. 1993;307(6910):982-986.
29. Meyer RJ, Haggerty RJ. Streptococcal infections in families. Factors altering individual susceptibility. Pediatrics. 1962;29:539-549.
30. Cohen S, Frank E, Doyle WJ, Skoner DP, Rabin BS, Gwaltney JM, Jr. Types of stressors that increase susceptibility to the common cold in healthy adults. Health Psychol. 1998;17(3):214-223.
31. Dobbs CM, Feng N, Beck FM, Sheridan JF. Neuroendocrine regulation of cytokine production during experimental infl uenza viral infection: effects of restraint stress-induced elevation in endogenous corticosterone. J Immunol. 1996;157(5):1870-1877.
32. Zhu Z, Tang W, Ray A, et al. Rhinovirus stimulation of interleukin-6 in vivo and in vitro . evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest. 1996;97(2):421-430.
33. Hayden FG, Fritz R, Lobo MC, Alvord W, Strober W, Straus SE. Local and systemic cytokine responses during experimental human infl uenza A virus infection. Relation to symptom formation and host defense. J Clin Invest. 1998;101(3):643-649.
34. Timothy GD. Novel approaches to the treatment of depression by modulating the hypothalamic - pituitary - adrenal axis. Hum Psychopharmacol. 2001;16(1):89-93.
35. Maes M. Major depression and activation of the infl ammatory response system. Adv Exper Med Biol. 1999;461:25.
36. Rothwell NJ, Hopkins SJ. Cytokines and the nervous system II: actions and mechanisms of action. Trends Neurosci. 1995;18(3):130.
37. Licinio J, Wong ML. The role of infl ammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection. Mol Psychiatry. 1999;4(4):317.
38. Goldberg JM, Moberg GP. Autonomic control of heart rate in the neonatal rhesus monkey. J Med Primatol. 1985;14(1):19-27.
39. Sternberg EM. Neuroendocrine regulation of autoimmune/inflammatory disease. J Endocrinol. 2001;169(3):429-435.
40. Schweizer M, Peterhans E. Oxidative stress in cells infected with bovine viral diarrhoea virus: a crucial step in the induction of apoptosis. J Gen Virol. 1999;80(Pt 5):1147-1155.
41. Hirai MY, Saito K. Post-genomics approaches for the elucidation of plant adaptive mechanisms to sulphur deficiency. J Exp Bot. 2004;55(404):1871-1879.
42. Visca P, Fabozzi G, Milani M, Bolognesi M, Ascenzi P. Nitric oxide and Mycobacterium leprae pathogenicity. IUBMB Life. 2002;54(3):95-99.
43. Fodor SP, Rava RP, Huang XC, Pease AC, Holmes CP, Adams CL. Multiplexed biochemical assays with biological chips. Nature. 1993;364(6437):555-556.
44. Southern EM, Maskos U. Parallel synthesis and analysis of large numbers of related chemical compounds: applications to oligonucleotides. J Biotechnol. 1994;35(2-3):217-227.
45. Schena M, Shalon D, Davis RW, Brown PO. Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science. 1995;270(5235):467-470.
46. Velculescu VE, Zhang L, Vogelstein B, Kinzler KW. Serial analysis of gene expression. Science. 1995;270(5235):484-487.
47. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem. 1975;250(10):4007-4021.
48. Yang IV, Chen E, Hasseman JP, et al. Within the fold: assessing differential expression measures and reproducibility in microarray assays. Genome Biol. 2002;3(11):research0062.
49. Butte A. The use and analysis of microarray data. Nat Rev Drug Discov. 2002;1(12):951-960.
50. Barlow C, Lockhart DJ. DNA arrays and neurobiology - what's new and what's next? Curr Opin Neurobiol. 2002;12(5):554-561.
51. Zamvil SS, Steinman L. Cholesterol-lowering statins possess antiinfl ammatory activity that might be useful for treatment of MS. Neurology. 2002;59(7):970-971.
52. Wilson HL, Aich P, Roche FM, et al. Molecular analyses of disease pathogenesis: Application of bovine microarrays. Vet Immunol Immunopathol. 2005;105(3-4):277-287.
53. Aich P, Jalal S, Czuba C, et al. Comparative approaches to the investigation of responses to stress and viral infection in cattle. Omics. 2007;11(4):413-434.
54. Aich P, Wilson HL, Kaushik RS, Potter AA, Babiuk LA, Griebel P. Comparative analysis of innate immune responses following infection of newborn calves with bovine rotavirus and bovine coronavirus. J Gen Virol. 2007;88(10):2749-2761.
55. Cogburn LA, Porter TE, Duclos MJ, et al. Functional genomics of the chicken-a model organism. Poult Sci. 2007;86(10):2059-2094.
56. Kingsmore SF, Lindquist IE, Mudge J, Beavis WD. Genome-wide association studies: progress in identifying genetic biomarkers in common, complex diseases. Biomarker Insights. 2007;283-292.
57. Sellier P. Genomics applied to the improvement of farm animals: a survey of the research projects funded in the frame of the French programme. Sci Aliments. 2007;27(2):133-42.
58. Wong C-W, Chen L. Bridging bench to clinic: roles of animal models for post-genomics drug discovery on metabolic diseases. Drug Discovery Res. 2007;465-478.
59. Allen JE, Pertea M, Salzberg SL. Computational gene prediction using multiple sources of evidence. Genome Res. 2004;14(1):142-148.
60. Quackenbush J. Data standards for 'omic' science. Nat Biotechnol. 2004;22(5):613-614.
61. Yang YH, Buckley MJ, Speed TP. Analysis of cDNA microarray images. Brief Bioinform. 2001;2(4):341-349.
62. Patton WF. Detection technologies in proteome analysis. J Chromatogr B Analyt Technol Biomed Life Sci. 2002 May 5;771(1-2):3-31.
63. Kislinger T, Gramolini AO, MacLennan DH, Emili A. Multidimensional protein identifi cation technology (MudPIT): technical overview of a profi ling method optimized for the comprehensive proteomic investigation of normal and diseased heart tissue. J Am Soc Mass Spectrom. 2005;16(8):1207-1220.
64. Wolters DA, Washburn MP, Yates JR, 3rd. An automated multidimensional protein identifi cation technology for shotgun proteomics. Anal Chem. 2001;73(23):5683-5690.
65. Zhang R, Sioma CS, Wang S, Regnier FE. Fractionation of isotopically labeled peptides in quantitative proteomics. Anal Chem. 2001;73(21):5142-5149.
66. Issaq HJ, Conrads TP, Prieto DA, Tirumalai R, Veenstra TD. SELDI-TOF MS for diagnostic proteomics. Anal Chem. 2003;75(7): 148A-155A.
67. Wulfkuhle JD, McLean KC, Paweletz CP, et al. New approaches to proteomic analysis of breast cancer. Proteomics. 2001;1(10):1205-1215.
68. Shadforth IP, Dunkley TP, Lilley KS, Bessant C. i-Tracker: For quantitative proteomics using iTRAQ. BMC Genomics. 2005;6(1):145.
69. Bollard ME, Stanley EG, Lindon JC, Nicholson JK, Holmes E. NMRbased metabonomic approaches for evaluating physiological infl uences on biofluid composition. NMR Biomed. 2005;18(3):143-162.
70. Ma SF, Grigoryev DN, Taylor AD, et al. Bioinformatic identifi cation of novel early stress response genes in rodent models of lung injury. Am J Physiol Lung Cell Mol Physiol. 2005;289(3):L468-L477.
71. Yagil Y, Yagil C. Genetic models of hypertension in experimental animals. Exp Nephrol. 2001;9(1):1-9.
72. Kelley KW. Stress and immune function: a bibliographic review. Ann Rech Vet. 1980;11(4):445-478.
73. Klein TW. Stress and infections. J Fla Med Assoc. 1993;80(6):409-411.
74. Emau P, Giri SN, Bruss ML. Viral-bacterial pneumonia in calves: effects on plasma eicosanoids and long chain fatty acids. Int J Tissue React. 1987;9(3):199-214.
75. Mitchell GB, Clark ME, Siwicky M, Caswell JL. Stress alters the cellular and proteomic compartments of bovine bronchoalveolar lavage fluid. Vet Immunol Immunopathol. 2008;125(1-2):111-125.
76. Beveridge JD, Mitchell GB, Brewer D, Clark ME, Caswell JL. Altered protein expression in neutrophils of calves treated with dexamethasone. Can J Vet Res. 2008;72(3):249-252.
77. Mitchell GB, Clark ME, Caswell JL. Alterations in the bovine bronchoalveolar lavage proteome induced by dexamethasone. Vet Immunol Immunopathol. 2007;118(3-4):283-293.
78. Babiuk LA, Ohmann HB, Gifford G, Czarniecki CW, Scialli VT, Hamilton EB. Effect of bovine alpha 1 interferon on bovine herpesvirus type 1-induced respiratory disease. J Gen Virol. 1985; 66(Pt 11):2383-2394.
79. Babiuk LA, Lawman MJ, Gifford GA. Use of recombinant bovine alpha 1 interferon in reducing respiratory disease induced by bovine herpesvirus type 1. Antimicrob Agents Chemother. 1987;31(5):752-757.
80. Yates WD, Stockdale PH, Babiuk LA, Smith RJ. Prevention of experimental bovine pneumonic pasteurellosis with an extract of Pasteurella haemolytica. Can J Comp Med. 1983;47(3):250-256.
81. Stookey JM, Gonyou HW. The effects of regrouping on behavioral and production parameters in finishing swine. J Anim Sci. 1994;72(11):2804-2811.
82. Hodgson PD, Aich P, Manuja A, et al. Effect of stress on viral-bacterial synergy in bovine respiratory disease: novel mechanisms to regulate inflammation. Comp Funct Genomics. 2005;6(4):244-250.
83. Jericho KW, Yates WD, Babiuk LA. Bovine herpesvirus-1 vaccination against experimental bovine herpesvirus-1 and Pasteurella haemolytica respiratory tract infection: onset of protection. Am J Vet Res. 1982;43(10):1776-1780.
84. Hodgson PD, Aich P, Manuja A, et al. Effect of stress on viral-bacterial synergy in bovine respiratory disease: Novel mechanisms to regulate inflammation. Comp Funct Genomics. 2005;6(4):244-250.
85. Aich P, Jalal S, Czuba C, et al. Comparative approaches to the investigation of responses to stress and viral infection in cattle. Omics. 2007;11(4):413-434.
86. Buckham Sporer KR, Weber PS, Burton JL, Earley B, Crowe MA. Transportation of young beef bulls alters circulating physiological parameters that may be effective biomarkers of stress. J Anim Sci. 2008;86(6):1325-1334.
87. Lomborg SR, Nielsen LR, Heegaard PM, Jacobsen S. Acute phase proteins in cattle after exposure to complex stress. Vet Res Commun. 2008;32(7):575-582.
88. Riondato F, D'Angelo A, Miniscalco B, Bellino C, Guglielmino R. Effects of road transportation on lymphocyte subsets in calves. Vet J. 2008;175(3):364-368.
89. Sporer KR, Xiao L, Tempelman RJ, Burton JL, Earley B, Crowe MA. Transportation stress alters the circulating steroid environment and neutrophil gene expression in beef bulls. Vet Immunol Immunopathol. 2008;121(3-4):300-320.
90. Slowik A, Turaj W, Pankiewicz J, Dziedzic T, Szermer P, Szczudlik A. Hypercortisolemia in acute stroke is related to the infl ammatory response. J Neurol Sci. 2002;196(1-2):27-32.
91. Le Jan C, Asso J. [Induction of interferon activity in nasal mucus by association of levamisole by systemic route - inactivated virus by local route (author's transl)]. Ann Rech Vet. 1980;11(3):307-312.
92. Hodgson PD, Aich P, Manuja A, et al. Effect of stress on viral-bacterial synergy in bovine respiratory disease: A review of potential mechanisms. Comp Funct Genomics. 2005;6:244-250.
93. Gershwin LJ, Berghaus LJ, Arnold K, Anderson ML, Corbeil LB. Immune mechanisms of pathogenetic synergy in concurrent bovine pulmonary infection with Haemophilus somnus and bovine respiratory syncytial virus. Vet Immunol Immunopathol. 2005;107(1-2):119-130.
94. Celis JE, Gromov P, Cabezon T, et al. Proteomic characterization of the interstitial fl uid perfusing the breast tumor microenvironment: a novel resource for biomarker and therapeutic target discovery. Mol Cell Proteomics. 2004;3(4):327-344.
95. Korth MJ, Katze MG. Unlocking the mysteries of virus-host interactions: does functional genomics hold the key? Ann N Y Acad Sci. 2002;975:160-168.
96. Choe LH, Aggarwal K, Franck Z, Lee KH. A comparison of the consistency of proteome quantitation using two-dimensional electrophoresis and shotgun isobaric tagging in Escherichia coli cells. Electrophoresis. 2005;26(12):2437-2449.
97. Chirase NK, Greene LW, Purdy CW, et al. Effect of transport stress on respiratory disease, serum antioxidant status, and serum concentrations of lipid peroxidation biomarkers in beef cattle. Am J Vet Res. 2004;65(6):860-864.
98. Mormede P, Soissons J, Bluthe RM, et al. Effect of transportation on blood serum composition, disease incidence, and production traits in young calves. Influence of the journey duration. Ann Rech Vet. 1982;13(4):369-384.